Transdermal Medical Patch Market

Transdermal Medical Patch Market contains market size and forecasts of Transdermal Medical Patch in global, including the following market information:

• Global Transdermal Medical Patch Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Transdermal Medical Patch Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Transdermal Medical Patch companies in 2021 (%)

The global Transdermal Medical Patch market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Methyl Salicylate-Based Patch Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Transdermal Medical Patch include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Gr?nenthal and IBSA Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Transdermal Medical Patch manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Transdermal Medical Patch Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Transdermal Medical Patch Market Segment Percentages, by Type, 2021 (%)

• Methyl Salicylate-Based Patch
• Rivastigmine Patch
• Fentanyl Patch
• Lidocaine Patch
• Diclofenac Patch
• Nicotine Patch
• Others

Global Transdermal Medical Patch Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Transdermal Medical Patch Market Segment Percentages, by Application, 2021 (%)

• Offline Channel
• Online Channel

Global Transdermal Medical Patch Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Transdermal Medical Patch Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Transdermal Medical Patch revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Transdermal Medical Patch revenues share in global market, 2021 (%)
• Key companies Transdermal Medical Patch sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Transdermal Medical Patch sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Hisamitsu Pharmaceutical
• Johnson & Johnson
• Novartis
• UCB Pharma
• Mylan
• Teva Pharmaceutical
• Nitto Denko
• Gr?nenthal
• IBSA Group
• GSK
• Luye Pharma Group
• Pfizer
• Chattem
• Dr Reddy?s Laboratories
• Bayer
• Mundipharma
• Endo International
• Beijing Tide Pharmaceutical